Hedvig Marie Egeland Nordeng

Image of Hedvig Marie Egeland Nordeng
Norwegian version of this page
Phone +47 22856604
Mobile phone +4745033984 45033984
Room 471
Username
Visiting address Gydas vei 8
Postal address Postboks 1068 Blindern 0316 OSLO

Academic Interests

Professional interests include perinatal pharmacoepidemiology and pharmacotherapy, with special focus on medication use and safety in pregnancy and lactation. 

Professor Nordeng is the holder of ERC STG Grant “DrugInPregnancy” (http://cordis.europa.eu/project/rcn/198436_en.html). 

Her expertise is in perinatal pharmacoepidemiology and pharmacotherapy in pregnancy and lactation. She has studied risks of prenatal exposure to medication on immediate pregnancy outcome (e.g. birth weight, malformations) and long term outcomes such as neurodevelopmental disorders and childhood cancer.

Dr. Nordeng is head of the PharmaTox Strategic Research Initiative at the Faculty of Mathematics and Natural Sciences, University of Oslo, Norway uniting over 30 researchers within Life Sciences at the MN Faculty, and the head of the National Research School in Pharmacy, uniting more than 100 PhD students in pharmaceutical sciences in Norway.

She has hosted guest scientists from USA, Austria, Sweden, The Netherlands and UK and supervised student exchanges through the Erasmus program.

She has a PhD in pharmacoepidemiology and pharmacotherapy on drug use during pregnancy, Faculty of Medicine, University of Oslo in 2005. MSc Pharm in 1997. Dr. Nordeng became a full professor at the Faculty of Mathematics and Natural Sciences in 2011.

She is currently responsible for recommendation about medication safety in pregnancy and breast feeding in Norwegian National Formulary (http://legemiddelhandboka.no/). 

As of 2018 she is an independent expert in the Pharmacovigilance Risk Assessment Committee (PRAC) which is the European Medicines Agency's (EMA) committee responsible for assessing and monitoring the safety of human medicines.

Dr. Nordeng has authored over 160 scientific articles, book chapters and national guidelines on drug use in pregnancy and lactation.

In 2016 she was awarded Pharmacist of the Year in Norway and in 2017 she was awarded the Titan prize for excellence in science dissemination by the UiO.

Teaching

 

Higher education and employment history

  • Professor, Department of pharmacy, University of Oslo, Norway, 2011 – present
  • Associate professor, Department of pharmacy, University of Oslo, Norway, 2007 – 2011
  • Researcher, The Norwegian Institute of Public Health (NIPH), Division of Mental Health, 20% position, 2005 – present
  • Department of Pharmacotherapeutics, Medical faculty, University of Oslo, Norway. Post doctoral position conducting research on drug safety on pregnancy, 2005 – 2007
  • Regional Drug Information centre. Part time position as advisor in pharmacovigilance work and counselling healthcare personnel in pharmacotherapeutical issues. 2005.
  • Doctorial work (dr. philos). Department of Pharmacotherapeutics, Medical faculty, University of Oslo, Norway. 1999 – 2004. Thesis on “Drug use in pregnancy and after delivery” with special focus on factors predicting drug use illness during pregnancy.
  • MSc in Pharmacy, School of Pharmacy, University of Oslo, Norway, 1997. Masters in analytical chemistry.

Appointments

  • Head of PharmaSafe Research Group at the School of Pharmacy 
  • Head of PharmaTox Strategic Research Enviroment at MatNat from 2015
  • Head of Norwegian PhD School in Pharmacy 2015 - 2021
  • Member of Scientific Board Norwegian Pharmaceutical Journal, 2008 - 2018
  • Member of the Editorial board: Journal of Population Therapeutics and Clinical Pharmacology, 2012 - 2018
  • Board member, National Council for ranking journals in Pharmacology, Toxicology, Pharmacy, 2010 - present
  • Mentor, Career Development Program for female post doc fellows at UiO, 2013

Cooperation

  • Division of Child Health and Development, National Institute of Public Health
  • Genetics Dpt., Biosciences Institute, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, Brazil
  • Center for Better Beginnings, School of Medicine, University of California, San Diego

  • Department of Epidemiology, Biostatistics and HTA, Radboud University Nijmegen Medical Center, Nijmegen
Tags: Pharmacoepidemiology, Registry-based research, Pharmacovigilance, Pregnancy, Lactation, ERC, Neurotoxicity, Life Science
Published Nov. 3, 2010 3:41 PM - Last modified July 7, 2021 8:35 AM